CRISPR Therapeutics AG (CRSP) Shares Issued (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Shares Issued of $4.8 million for Q1 2026, down 29.22% sequentially from $6.7 million in Q4 2025, and down 39.44% YoY from $7.9 million in Q1 2025.
CRISPR Therapeutics AG (CRSP) Shares Issued (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Shares Issued for 12 years, with the latest figure at $4.8 million in Q1 2026.
- Quarterly Shares Issued fell 39.44% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (down 39.44% YoY) and the FY2025 annual result came in at $6.7 million, down 7.42% from the prior year.
- Shares Issued eased to $4.8 million in Q1 2026 per CRSP's latest filing, from $6.7 million in the prior quarter.
- Over five years, Shares Issued peaked at $8.2 million in Q1 2022 and troughed at $4.6 million in Q3 2022.
- A 5-year average of $6.7 million and a median of $7.2 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2023: Shares Issued slumped 41.21% in 2022, then surged 54.2% in 2023.
- Over 5 years, Shares Issued stood at $7.2 million in 2022, then dropped by 0.36% to $7.2 million in 2023, then climbed by 1.17% to $7.3 million in 2024, then decreased by 7.42% to $6.7 million in 2025, then slipped by 29.22% to $4.8 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $4.8 million, $6.7 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 6.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.86 Mn |
| Jun 30, 2026 | 6.86 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 7.89 Mn |
| Mar 31, 2025 | 7.89 Mn |
| Dec 31, 2024 | 7.29 Mn |
| Dec 31, 2024 | 7.29 Mn |
| Sep 30, 2024 | 7.05 Mn |
| Sep 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 7.16 Mn |
| Mar 31, 2024 | 7.16 Mn |